MA
KALA icon

MCF Advisors’s KALA BIO KALA Stock Holding History

MCF Advisors’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$8.77K – 856
2022
Q4 		$8.77K Buy
+5
New +$1.98K ﹤0.01% 550
2022
Q3 		– Sell
-3
Closed -$3K – 848
2022
Q2 		$3K Hold
3
– – ﹤0.01% 594
2022
Q1 		$12K Buy
+3
New +$7.86K ﹤0.01% 509
2021
Q4 		– Sell
-3
Closed -$22K – 384
2021
Q3 		$22K Hold
3
– – ﹤0.01% 403
2021
Q2 		$45K Hold
3
– – ﹤0.01% 300
2021
Q1 		$57K Hold
3
– – 0.01% 256
2020
Q4 		$57K Hold
3
– – 0.01% 232
2020
Q3 		$63K Hold
3
– – 0.01% 216
2020
Q2 		$89K Hold
3
– – 0.01% 189
2020
Q1 		$74K Buy
+3
New +$47.9K 0.01% 200

Other funds holding KALA

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCF Advisors's KALA Position: Q1 2023 in Review

MCF Advisors sold out of KALA BIO (KALA) in Q1 2023, closing a stake of 5 shares — an estimated $8.77K sold.

MCF Advisors first reported a position in KALA in Q1 2020 and held it in 10 quarters. The position peaked at $89K in Q2 2020. 21 funds tracked by Wall St. Rank hold KALA as of Q1 2023.

  • MCF Advisors reported no remaining KALA BIO position as of Q1 2023 after selling out during the quarter.
  • MCF Advisors sold 5 KALA BIO shares in Q1 2023, an estimated $8.77K.
  • MCF Advisors first reported a position in KALA BIO in Q1 2020 and held it in 10 quarters.
  • MCF Advisors's KALA BIO position peaked at $89K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held KALA BIO as of Q1 2023.

Based on MCF Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.